Regulatory (104)

DateCircularTags
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply …
BSE announces movement of 13 securities into various stages of Graded Surveillance Measure (GSM) framework for enhanced monitoring.
SEBI mandates all mutual fund investors to either nominate or formally opt-out with proper authentication, effective December 15, 2025 for …
SEBI order under Section 12(3) of SEBI Act, 1992 against Investment Adviser Krishna Kumar Jaiswal for being unreachable and not maintaining …
SEBI order under Section 12(3) of SEBI Act, 1992 against Investment Adviser Krishna Kumar Jaiswal for non-availability during inspection and …
SEBI order under Section 12(3) of SEBI Act, 1992 against Investment Adviser Krishna Kumar Jaiswal for non-cooperation during inspection and …
NSE announces inclusion of securities in Short-Term Additional Surveillance Measure (ST-ASM) framework effective December 09, 2025, with two …
SEBI order under Section 12(3) of SEBI Act, 1992 read with Regulation 30A of SEBI (Intermediaries) Regulations, 2008 against Investment …
BSE removes the Rs. 10 crores per PAN subscription limit for Aditya Birla Sun Life Medium Term Plan and Credit Risk Fund effective December …
Four securities have been moved to different GSM stages: two companies moved to Stage II and two companies moved to Stage III under the …